Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OAX Equities |
Sektor | Hälsovård |
Industri | Bioteknik |
3.3.2023 15:44:45 CET | Aqua Bio Technology ASA | Non-regulatory press releases
ABT has been granted a US patent for use of Chaga in cosmetic formulation. The Chaga mushroom grows on birch trees throughout the northern hemisphere. The extract from Chagas mushroom has shown good results on wrinkles and general skin improvement. The extract from Chagas mushroom can be beneficial for anyone suffering from skin conditions such as acne, allergic reactions, rashes, dermatitis, psoriasis, rosacea and eczema. The US patent secures ABT’s use of this ingredient in existing and future cosmetic products and prohibits other players to use this ingredient without a specific license from ABT.
Co-location:
From 1 March 2023, Hofseth Biocare ASA, Cosmed Beauty AS and Aqua Bio Technology ASA are co-located in Bygdøy Alle 3 in Oslo. The co-location will lead to increased synergies between the companies that all have the same main shareholder.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
- Håvard Lindstrøm, 004794132288, hl@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.